Susan Robinson
Nurse Practitioner · Indian Land, SCNPI 1053382267
Payments from drug & device makers
Across 169 payments — averaging $17.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$737
- Lilly USA, LLC$442
- Pfizer$386
- AbbVie$248
- Biohaven Pharmaceutical Holding Company Ltd.$171
- Boehringer Ingelheim$159
- plus $793 from 17 others
What the payments were for
- Food & beverage$2,936100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 53 | $737 |
| Lilly USA, LLC | 25 | $442 |
| Pfizer | 22 | $386 |
| AbbVie | 13 | $248 |
| Biohaven Pharmaceutical Holding Company Ltd. | 10 | $171 |
| Boehringer Ingelheim | 3 | $159 |
| AstraZeneca | 9 | $155 |
| Exact Sciences | 7 | $117 |
| Amgen | 4 | $91 |
| Esperion Therapeutics, Inc. | 3 | $55 |
| Astellas Pharma US Inc | 3 | $54 |
| Sumitomo Pharma America, Inc. | 2 | $45 |
| Biohaven Pharmaceuticals, Inc. | 2 | $40 |
| Kowa Pharmaceuticals America, Inc. | 2 | $40 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $32 |
| GSK | 2 | $28 |
| Cequr Corporation | 1 | $25 |
| Sanofi-aventis U.S. LLC | 1 | $23 |
| Amarin Pharma, Inc. | 1 | $20 |
| Novartis | 1 | $20 |
| Acerus Pharmaceuticals Corporation | 1 | $19 |
| Mylan Specialty L.p. | 1 | $13 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,936 in reported general payments places this provider in the 85th percentile of 1,346 nurse practitioner providers in South Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Rosuvastatin Calcium | 20 | $154 |
| Amlodipine Besylate | 20 | $154 |
| Atenolol | 13 | $144 |
| Lisinopril | 17 | $111 |
| Losartan Potassium | 12 | $64 |
| Atorvastatin Calcium | 18 | $9 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Indian Land
- Kayce HooverIndian Land$7K
- Jenna DavisColumbia$202K
- David WiltGreenville$90K
- Whitney ReedCharleston$54K
- Mary JohnsonCharleston$34K
- Amanda HareCharleston$30K
- Kellie McLainCharleston$28K
- Colleen BoydSummerville$21K
- Mae BurtonGreenville$21K
- Melissa BramanteColumbia$19K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.